Skip to main content
. 2010 Jun 30;20(11):2609–2616. doi: 10.1007/s00330-010-1850-3

Table 1.

Summary of all studies mentioned in the article

Modality Gastric volume (ml)
Basal After glucagon After erythromycin
Barostat 225 ± 52 561 ± 58* 149 ± 61
MR imaging 331 ± 56 720 ± 65* 206 ± 66
HHS Vulnerability Disclosure